Back to top
Live:
Coronavirus Updates

In the ongoing effort to contain the impact of the coronavirus pandemic, clinical trials are underway to test several drugs for their effectiveness as potential COVID-19 treatments.

A randomized, placebo-controlled, double-blind trial of a drug initially developed to treat Ebola is on clinical trial at Northwestern Medicine in Illinois. Similar trials are being done by Cedars-Sinai and the University of California-Davis. The trio are part of a larger global trial project, sponsored by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), to help find a COVID-19 treatment.

COVID-19 Drug Trial Launches at Northwestern Medicine

Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19. The drug being tested is remdesivir, a novel anti-viral drug developed to treat Ebola and which has subsequently been found, in animal models, to have antiviral activity against coronaviruses including MERS and now SARS-Cov-2, the virus that causes COVID-19 disease.


https://news.northwestern.edu/stories/2020/03/covi...

COVID-19: Cedars-Sinai Joins Worldwide Trial of Antiviral Drug

Cedars-Sinai has joined an international effort to test an experimental antiviral drug as a potential treatment for COVID-19 (coronavirus). The institution expects to enroll its first clinical trial participant this week.

Cedars-Sinai is among dozens of sites around the world participating in the clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH). The trial is evaluating remdesivir, an investigational drug developed by the biopharmaceutical company Gilead Sciences Inc., based in Foster City, California.


https://www.cedars-sinai.org/newsroom/covid-19-ced...

UC Davis Launches 2 Clinical Studies to Treat COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

The studies are evaluating the safety and effectiveness of two drugs — the investigational antiviral remdesivir, and sarilumab, a drug that blocks the body's acute inflammatory response.


https://www.ucdavis.edu/coronavirus/news/uc-davis-...

Read more about each trial here:

COVID-19 Drug Trial Launches at Northwestern Medicine

COVID-19: Cedars-Sinai Joins Worldwide Trial of Antiviral Drug

UC Davis Launches 2 Clinical Studies to Treat COVID-19

Watch our latest HD Live! as we take a look at Philly Fighting Covid, a nonprofit organization run by graduate students from Drexel University that aims to help with mass COVID-19 vaccination in Philadelphia.

Mabel Jong from our liveblog team speaks with Andrei Doroshin, founder of Philly Fighting Covid.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

HD Live! Videos

Watch our latest HD Live! as we take a deep dive into the vaccine rollout across the country.

Mabel Jong from our liveblog team speaks with Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota and a member of the Biden COVID-19 Advisory Board.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! is a conference wrap-up of the American Heart Association Scientific Sessions 2020.

Mabel Jong from our liveblog team speaks with Dr. Donald Lloyd-Jones, American Heart Association President-Elect, for a summary of the highlights of the AHA Scientific Sessions 2020.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is on how healthcare in America could be impacted by a Trump or Biden victory.

Mabel Jong from our liveblog team speaks with Marianne Udow-Phillips, director of the Center for Health and Research Transformation at the University of Michigan, and Brian Blase, who served as a healthcare adviser to President Trump from 2017-2019 and is now president and CEO of Blase Policy Strategies.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is an overview of IDWeek, the annual meeting of leading infectious disease experts worldwide.

Mabel Jong from our liveblog team speaks with Dr. Inger Damon and Dr. Tom Talbot, IDWeek Chairs, for a summary of the latest data on a range of infectious diseases, including COVID-19.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is an overview of the American Academy of Pediatrics (AAP) national conference and exhibition.

Mabel Jong from our liveblog team speaks with AAP's Dr. Elizabeth Murray on the key takeaways of the event.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is on what could happen this flu season as COVID-19 still rages on across the country. How can we protect ourselves, and what can we and the health care system do to prepare for and potentially prevent a twindemic?

Mabel Jong from our liveblog team speaks with Dr. Nadia Eltaki, director of clinical operations at Sibley Memorial Hospital, on guidance on how to protect yourself and how a twindemic could impact the health care system.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is on loneliness and social isolation and how they can affect mental health. Plus, learn more about the survey we conducted with The Harris Poll on Americans and their use and knowledge of face masks and COVID-19.

Mabel Jong from our liveblog team speaks with Dr. Carla Perissinotto, a geriatrician and the associate chief for geriatrics clinical programs at UCSF, on advice on how to better care for seniors who might be more vulnerable to social isolation, and Kathy Steinberg, vice president of public release research at The Harris Poll, on the results of the HealthDay/The Harris Poll survey.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is on the upcoming COVID-19 vaccine and how the United States would need to prepare for a mass vaccination program.

Mabel Jong from our liveblog team speaks with Dr. Amesh Adalja from the Center for Health Security at Johns Hopkins University and Dr. Kelly Moore from Vanderbilt School of Medicine and associate director for immunization education with the Immunization Action Coalition.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.